Diallyl disulfide can suppress the accumulation/activation of macrophages in adipose tissue and inhibit the release of CCL2 from adipocytes lowering the inflammatory status induced by obesity [31]. The gene discussed is CCL2; the disease is obesity due to melanocortin 4 receptor deficiency.